Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials.
Connock M, Armoiry X, Tsertsvadze A, Melendez-Torres GJ, Royle P, Andronis L, Clarke A. Connock M, et al. Among authors: royle p. BMC Cancer. 2019 Apr 25;19(1):392. doi: 10.1186/s12885-019-5507-6. BMC Cancer. 2019. PMID: 31023244 Free PMC article.
Incidence of sudden cardiac death in the young: a systematic review.
Couper K, Putt O, Field R, Poole K, Bradlow W, Clarke A, Perkins GD, Royle P, Yeung J, Taylor-Phillips S. Couper K, et al. Among authors: royle p. BMJ Open. 2020 Oct 7;10(10):e040815. doi: 10.1136/bmjopen-2020-040815. BMJ Open. 2020. PMID: 33033034 Free PMC article.
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer.
Gallacher D, Auguste P, Royle P, Mistry H, Armoiry X. Gallacher D, et al. Among authors: royle p. Clin Drug Investig. 2019 Dec;39(12):1153-1174. doi: 10.1007/s40261-019-00859-5. Clin Drug Investig. 2019. PMID: 31583605
133 results